ArticleJournal of oncology2020

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.

Kiyohiro Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.